Search
Metavone managing director Stuart Gunzburg. Photo: Attila Csaszar

Metavone seeks ASX listing

Perth-based biotechnology company Metavone hopes to list on the ASX next month after raising up to $5 million from investors in an initial public offering.

Login

(existing subscribers)

The password field is case sensitive.
Request new password

Add your comment

Medibio (MEB)

Share Price

Closing price for the last 90 trading days
Source: Morningstar

Total Shareholder Return as at 31/08/18

1 year TSR5 year TSR
274thProteomics International Laboratories23%0%
578thTransaction Solutions International-22%12%
603rdSpectur-27%0%
776thMedibio-58%9%
737 WA (and selected non WA) listed companies ranked by 1 year TSR relative to other companies with similar revenue
Source: Morningstar

Share Transactions

18/06/18
$0 Issued
18/06/18
$0 Issued
18/06/18
$0 Issued
Total value as at the date of the transaction
Source: Morningstar

Revenue

128th↑Spectur$2.5m
129th↓Medibio$2.5m
131st↑Transaction Solutions International$2.3m
132nd↓Proteomics International Laboratories$2.1m
237 listed industrial companies ranked by revenue.
Source: Morningstar

Remuneration from Medibio

819thFrank Prendergast$119k
515thChris Indermaur$50k
Ranked by total remuneration from all listed WA companies

BNiQ Disclaimer